HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside.

Abstract
The cancerostatic effect of 6-purinyl-N-(2-chloroethyl)thiocarbamate (Cloturin VUFB, VUFB-15686) was studied in detail in mice and rats bearing transplantable tumors. The cytotoxic activities were measured by determining the incorporation rate of 5-iodo-2'-deoxy[6-3H]uridine and uniformly labeled [U-14C]amino acid mixture into trichloroacetic acid-insoluble fraction of Yoshida ascites reticulosarcoma cells during a short-term incubation with the drug. From the results obtained it follows that the new substance is therapeutically more effective in comparison with 6-mercaptopurine (NSC-755). A therapeutic synergism of Cloturin with cytosine arabinoside (NSC-63978) was observed.
AuthorsM Mĕlka, J Krepelka, M Miko, S Pokorná, I Kejhová, R Reichlová, M Beitová, J Grimová, A Kargerová, J Sedivá
JournalNeoplasma (Neoplasma) Vol. 36 Issue 4 Pg. 419-25 ( 1989) ISSN: 0028-2685 [Print] Slovakia
PMID2671756 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • DNA, Neoplasm
  • Mustard Compounds
  • RNA, Neoplasm
  • Cytarabine
  • Cloturin
  • Mercaptopurine
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cytarabine (administration & dosage, therapeutic use)
  • DNA, Neoplasm (biosynthesis, drug effects)
  • Female
  • Lymphoma, Large B-Cell, Diffuse (drug therapy, metabolism)
  • Melanoma, Experimental (drug therapy)
  • Mercaptopurine (administration & dosage, analogs & derivatives, therapeutic use)
  • Mice
  • Mice, Inbred C57BL
  • Mustard Compounds (administration & dosage, therapeutic use)
  • Neoplasms, Experimental (drug therapy)
  • RNA, Neoplasm (biosynthesis)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: